Loading...

2360: Rising Earnings Multiples Will Increase Downside Risk Ahead

Published
08 Dec 24
Updated
15 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
88.6%
7D
-1.0%

Author's Valuation

NT$809.174.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 15 Nov 25

Fair value Increased 8.98%

2360: Future Revenue Upside Expected To Offset Profit Margin Pressures

Analysts have increased their fair value estimate for Chroma ATE from $742.50 to approximately $809.17. They cite improved revenue growth expectations, despite a slight drop in profit margin forecasts and a higher projected future P/E ratio.

Shared on 01 Nov 25

Fair value Increased 38%

Analysts have raised Chroma ATE's fair value estimate from $536.25 to $742.50. This change reflects heightened optimism driven by improved revenue growth projections and stronger margins.

Shared on 18 Oct 25

Analysts have reaffirmed their fair value estimate for Chroma ATE at $536.25. They cite minimal changes in company fundamentals and performance metrics as the basis for maintaining their target.

Shared on 03 Oct 25

Fair value Increased 3.37%

Analysts have raised their price target for Chroma ATE from $518.75 to $536.25, citing an improved profit margin outlook and minor adjustments in growth and valuation metrics. Valuation Changes Fair Value Estimate: Increased slightly from NT$518.75 to NT$536.25.

Shared on 04 Aug 25

Fair value Increased 15%

The upward revision in Chroma ATE's price target is primarily driven by stronger consensus revenue growth forecasts, with the fair value estimate increasing from NT$451.25 to NT$501.67. What's in the News Shareholders approved amendments to the Articles of Incorporation.

Shared on 01 May 25

Fair value Decreased 9.09%

Shared on 23 Apr 25

Fair value Decreased 1.38%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 0.96%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 1.30%

AnalystConsensusTarget has decreased profit margin from 30.1% to 26.7%.